Cost-effectiveness and NPV
In terms of cost-effectiveness, the estimated cost per reduction in an ASD diagnosis at age 3 years was A $37 181 (US $26 138). When modeled to age 12 years, NPV cost savings were estimated at A $10 695 (US $7519) per child enrolled in iBASIS-VIPP (A $15 826 less A $5131 treatment cost differential; 